application): The applicant has previously demonstrated that impaired endothelium-dependent vasodilation in response to hormonal agonists and shear stress in patients with heart failure is attributable to reduced synthetic activity of the L-arginine-nitric oxide metabolic pathway and that endothelial dysfunction in heart failure is reversible with physical training. These findings indicate that endothelial dysfunction is a modifiable determinant of reduced aerobic capacity in heart failure and thereby is a target for therapy. We now propose: 1) to perform controlled clinical trials to determine whether specific therapies which decrease oxidative stress (Vitamin C, Vitamin E), increase L-arginine availability (supplemental oral L-arginine), or increase cGMP-mediated vasodilation (sildenafil) chronically enhance endothelial function in patients with heart failure; 2) to determine the role of endothelial dysfunction in disease progression with serial assessment of endothelial function in a large population of ambulatory patients with heart failure; and 3) to identify specific cellular mechanisms which contribute to impaired nitric oxide synthesis in heart failure with studies in cell culture. In clinical studies, endothelial function will be assessed non-invasively with a battery of tests for physiological testing of flow-mediated nitric oxide-induced vasodilation (Doppler ultrasonography and venous occlusion plethysmography) and determination of nitric oxide metabolism (isotope tracer techniques with '5N-L-arginine and measurement of nitric oxide production in expired gases). In laboratory studies, PKC and PKBIAkt activation, eNOS-calveolin-1 interactions, and regulation of substrate availability for eNOS (L-arginine transport and ADMA metabolism) will be investigated with molecular biology techniques in cultured human endothelial cells incubated with autocrine/paracrine factors and serum from normal subjects and patients with heart failure. The hypotheses to be tested are: 1) endothelial dysfunction is reversible with chronic interventions to decrease oxidative stress, increase availability of L-arginine, and enhance cGMP-dependent vasodilator effector mechanisms in vascular smooth muscle; 2) endothelial dysfunction is linked to disease progression in heart failure; and 3) reduced synthetic activity of the L-arginine-nitric oxide metabolic pathway in heart failure is attributable serum-induced decreases in PKC isoform or PKB/Akt activation, increased inhibitory eNOS-caveolin-1 interactions, or reduced substrate availability for eNOS (due to decreased L-arginine transport or decreased ADMA metabolism). Proposed studies will provide new data to develop novel therapeutic strategies to improve outcome in patients with heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051433-08
Application #
6665254
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Liang, Isabella Y
Project Start
1995-08-01
Project End
2005-02-28
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
8
Fiscal Year
2003
Total Cost
$327,000
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Zheng, Haoyi; Patel, Milan; Cable, Ritchard et al. (2007) Insulin sensitivity, vascular function, and iron stores in voluntary blood donors. Diabetes Care 30:2685-9
Androne, Ana Silvia; Hryniewicz, Katarzyna; Hudaihed, Alhakam et al. (2006) Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure. Am J Cardiol 97:685-9
Zheng, Haoyi; Patel, Milan; Hryniewicz, Katarzyna et al. (2006) Association of extended work shifts, vascular function, and inflammatory markers in internal medicine residents: a randomized crossover trial. JAMA 296:1049-50
Katz, Stuart D; Hryniewicz, Katarzyna; Hriljac, Ingrid et al. (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111:310-4
Zheng, Haoyi; Cable, Ritchard; Spencer, Bryan et al. (2005) Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 25:1577-83
Zheng, Haoyi; Dimayuga, Clarito; Hudaihed, Alhakam et al. (2002) Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects. Arterioscler Thromb Vasc Biol 22:E15-8